Angiotensinogen G(-6)A polymorphism is associated with the elevation of blood pressure in the hypertensive disorders of pregnancy

Twin Research and Human Genetics

Volumn 9, Issue 1, 2006, Pages 76-80

  Shim, Soon Sup ^a   Jun, Jong Kwan ^a   Park, Joong Shin ^a   Hur, Yoon Mi ^b   Choi, Young Min ^a   Yoon, Bo Hyun ^a   Syn, Hee Chul ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN;

ADULT; ARTICLE; BLOOD PRESSURE; CHRONIC DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MEDICAL RECORD; NULLIPARA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RESTRICTION FRAGMENT;

ANALYSIS OF VARIANCE; ANGIOTENSINOGEN; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; KOREA; LOGISTIC MODELS; PHENOTYPE; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 33644891609     PISSN: 18324274     EISSN: None     Source Type: Journal    
DOI: 10.1375/183242706776402966     Document Type: Article

References (24)

1. ACOG practice bulletin. (2002). Diagnosis and management of preeclampsia and eclampsia. Number 33, January. American College of Obstetricians and Gynecologists. International Journal of Gynaecology and Obstetrics, 77, 67-75.
2. ACOG technical bulletin. (1996). Hypertension in pregnancy. Number 219, January (replaces no. 91, February 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. International Journal of Gynaecology and Obstetrics, 53, 175-183.
3. Bashford, M. T., Hefler, L. A., Vertrees, T. W., Roa, B. B., & Gregg, A. R. (2001). Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia. American Journal of Obstetrics and Gynecology, 184, 1345-135.
4. Brand-Herrmann, S.-M., Kopke, K., Reichenberger, F., Schmidt-Petersen, K., Reineke, T., Paul, M., Zidek, W., & Brand, E. (2004). Angiotensinogen promoter haplotypes are associated with blood pressure in untreated hypertensives. Journal of Hypertension, 22, 1289-1297.
5. Caulfield, M., Lavender, P., Newell-Price, J., Kamdar, S., Farrall, M., & Clark, A. J. (1996). Angiotensinogen in human essential hypertension. Hypertension, 28, 1123-1125.
6. Cnattingius, S., Reilly, M., Pawitan, Y., & Lichtenstein, P. (2004). Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: A population-based Swedish cohort study. American Journal of Medical Genetics. Part A, 130, 365-371.
7. Duckitt, K., & Harrington, D. (2005). Risk factors for preeclampsia at antenatal booking: Systematic review of controlled studies. British Medical Journal, 330, 565-567.
8. Guo, G., Wilton, A. N., Fu, Y., Qiu, H., Brennecke, S. P., & Cooper, D. W. (1997). Angiotensinogen gene variation in a population case-control study of preeclampsia/eclampsia in Australians and Chinese. Electrophoresis, 18, 1646-1649.
9. Hegele, R. A., Harris, S. B., Hanley, A. J., Sun, F., Connelly, P. W., & Zinman, B. (1998). -6A promoter variant of angiotensinogen and blood pressure variation in Canadian Oji-Cree. Journal of Human Genetics, 43, 37-11.
10. Inoue, I., Nakajima, T., Williams, C. S., Quackenbush, J., Puryear, R., Powers, M., Cheng, T., Ludwig, E. H., Sharma, A. M., Hata, A., Jeunemaitre, X., & Lalouel, J. M. (1997) A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. Journal of Clinical Investigation, 99, 1786-1797.
11. Iwai, N., Shimoike, H., Ohmichi, N., & Kinoshita, M. (1995). Angiotensinogen gene and blood pressure in the Japanese population. Hypertension, 25, 688-693.
12. Jeunemaitre, X., Inoue, I., Williams, C., Charru, A., Tichet, J., Powers, M., Sharma, A. M., Gimenez-Roqueplo, A. P., Hata, A., Corvol, P., & Lalouel, J. M. (1997) Haplotypes of angiotensinogen in essential hypertension. American Journal of Human Genetics, 60, 1448-1460.
13. Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., Hunt, S. C., Hopkins, P. N., Williams, R. R., & Lalouel, J. M. (1992). Molecular basis of human hypertension: Role of angiotensinogen. Cell, 71, 169-180.
14. Lalouel, J.-M., & Rohrwasser, A. (2002). Power and replication in case-control studies. American Journal of Hypertension, 15, 201-205.
15. Morgan, L., Pipkin, B. F., & Kalsweker, N. (1996). Angiotensinogen: Molecular biology, biochemistry, and physiology. The International Journal of Biochemistry and Cell Biology, 28, 1211-1222.
16. Morgan, L., Crawshaw, S., Baker, P. N., Broughton, P. E, & Kalsheker, N. (1999). Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia. British Journal of Obstetrics and Gynaecology, 106, 244-251.
17. Morgan, T., Craven, C., Lalouel, J. M., & Ward, K. (1999). Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. American Journal of Obstetrics and Gynecology, 180, 95-102.
18. National High Blood Pressure Education Program Working Group. (2000). Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. American Journal of Obstetrics and Gynecology, 183, S1-S22.
19. Skjaerven, R., Vatten, L. J., Wilcox, A. J., Ronning, T., Irgens, L. M., & Lie, R. T. (2005). Recurrence of pre-eclampsia across generations: Exploring fetal and maternal genetic components in a population based cohort. British Medical Journal, 331, 877-881.
20. SPSS Inc. (2001). SPSS for Windows (Release 11.0.1) [Computer software]. Chicago: SPSS, Inc.
21. Suzuki, Y., Tanemura, M., Suzuki, Y., Murakami, I., & Suzumori, K. (1999). Is angiotensinogen gene polymorphism associated with hypertension in pregnancy? Hypertension in Pregnancy, 18, 261-271.
22. Ward, K., Hata, A., Jeunemaitre, X., Helin, C., Nelson, L., Namikawa, C., Farrington P. F., Ogasawara M., Suzumori K., & Tomoda, S. (1993). A molecular variant of angiotensinogen associated with preeclampsia. Nature Genetics, 4, 59-61.
23. Wikstrom, A.-K., Haglund, B., Olovsson, M., & Lindeberg, S. N. (2005). The risk of maternal ischaemic heart disease after gestational hypertensive disease. An International Journal of Obstetrics and Gynaecology, 112, 1486-1491.
24. Wilson, B. J., Watson, M. S., Prescott, G. J., Sunderland, S., Campbell, D. M., Hannaford, P., & Smith, W. C. (2003). Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: Results from cohort study. British Medical Journal, 326, 845-851.